| Year |
Citation |
Score |
| 2017 |
Ilina EI, Armento A, Sanchez LG, Reichlmeir M, Braun Y, Penski C, Capper D, Sahm F, Jennewein L, Harter PN, Zukunft S, Fleming I, Schulte D, Le Guerroué F, Behrends C, et al. Effects of soluble CPE on glioma cell migration are associated with mTOR activation and enhanced glucose flux. Oncotarget. 8: 67567-67591. PMID 28978054 DOI: 10.18632/Oncotarget.18747 |
0.325 |
|
| 2016 |
Jennewein L, Ronellenfitsch MW, Antonietti P, Ilina EI, Jung J, Stadel D, Flohr LM, Zinke J, von Renesse J, Drott U, Baumgarten P, Braczynski AK, Penski C, Burger MC, Theurillat JP, et al. Diagnostic and clinical relevance of the autophago-lysosomal network in human gliomas. Oncotarget. PMID 26956048 DOI: 10.18632/Oncotarget.7910 |
0.306 |
|
| 2015 |
Harter PN, Jennewein L, Baumgarten P, Ilina E, Burger MC, Thiepold AL, Tichy J, Zörnig M, Senft C, Steinbach JP, Mittelbronn M, Ronellenfitsch MW. Immunohistochemical Assessment of Phosphorylated mTORC1-Pathway Proteins in Human Brain Tumors. Plos One. 10: e0127123. PMID 25993328 DOI: 10.1371/Journal.Pone.0127123 |
0.302 |
|
| 2013 |
Naumann U, Harter PN, Rubel J, Ilina E, Blank AE, Esteban HB, Mittelbronn M. Glioma cell migration and invasion as potential target for novel treatment strategies Translational Neuroscience. 4: 314-329. DOI: 10.2478/S13380-013-0126-1 |
0.311 |
|
| Show low-probability matches. |